These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37726883)

  • 1. Using Regression Equations to Enhance Interpretation of Histology Lesions of Kidney Transplant Rejection.
    Sikosana MLN; Reeve J; Madill-Thomsen KS; Halloran PF;
    Transplantation; 2024 Feb; 108(2):445-454. PubMed ID: 37726883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification.
    Mauiyyedi S; Crespo M; Collins AB; Schneeberger EE; Pascual MA; Saidman SL; Tolkoff-Rubin NE; Williams WW; Delmonico FL; Cosimi AB; Colvin RB
    J Am Soc Nephrol; 2002 Mar; 13(3):779-787. PubMed ID: 11856785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concurrent acute cellular rejection is an independent risk factor for renal allograft failure in patients with C4d-positive antibody-mediated rejection.
    Matignon M; Muthukumar T; Seshan SV; Suthanthiran M; Hartono C
    Transplantation; 2012 Sep; 94(6):603-11. PubMed ID: 22932115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Banff Component Scoring-based Histologic Assessment of Bortezomib-based Antibody-mediated Rejection Therapy.
    Sadaka B; Ejaz NS; Shields AR; Cardi MA; Wadih G; Witte D; Abu Jawdeh BG; Alloway RR; Woodle ES
    Transplantation; 2015 Aug; 99(8):1691-9. PubMed ID: 25803498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Banff-based histologic chronicity index is associated with graft loss in patients with a kidney transplant and antibody-mediated rejection.
    Haas M; Mirocha J; Huang E; Najjar R; Peng A; Sethi S; Vo A; Anglicheau D; Jordan SC; Rabant M
    Kidney Int; 2023 Jan; 103(1):187-195. PubMed ID: 36332728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Probabilistic Approach to Histologic Diagnosis of Antibody-Mediated Rejection in Kidney Transplant Biopsies.
    Halloran PF; Famulski KS; Chang J
    Am J Transplant; 2017 Jan; 17(1):129-139. PubMed ID: 27340822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using Molecular Phenotyping to Guide Improvements in the Histologic Diagnosis of T Cell-Mediated Rejection.
    Reeve J; Chang J; Salazar ID; Lopez MM; Halloran PF
    Am J Transplant; 2016 Apr; 16(4):1183-92. PubMed ID: 26730747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relating Molecular T Cell-mediated Rejection Activity in Kidney Transplant Biopsies to Time and to Histologic Tubulitis and Atrophy-fibrosis.
    Madill-Thomsen KS; Böhmig GA; Bromberg J; Einecke G; Eskandary F; Gupta G; Myslak M; Viklicky O; Perkowska-Ptasinska A; Solez K; Halloran PF;
    Transplantation; 2023 May; 107(5):1102-1114. PubMed ID: 36575574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Banff Human Organ Transplant Transcripts Correlate with Renal Allograft Pathology and Outcome: Importance of Capillaritis and Subpathologic Rejection.
    Rosales IA; Mahowald GK; Tomaszewski K; Hotta K; Iwahara N; Otsuka T; Tsuji T; Takada Y; Acheampong E; Araujo-Medina M; Bruce A; Rios A; Cosimi AB; Elias N; Kawai T; Gilligan H; Safa K; Riella LV; Tolkoff-Rubin NE; Williams WW; Smith RN; Colvin RB
    J Am Soc Nephrol; 2022 Dec; 33(12):2306-2319. PubMed ID: 36450597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of Complement-binding Donor-specific Antibodies, Not IgG-antibody Strength Nor C4d Status, at Antibody-mediated Rejection Diagnosis Is an Independent Predictor of Kidney Graft Failure.
    Malheiro J; Santos S; Tafulo S; Dias L; Martins S; Fonseca I; Almeida M; Pedroso S; Beirão I; Castro-Henriques A; Cabrita A
    Transplantation; 2018 Nov; 102(11):1943-1954. PubMed ID: 29757900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody-mediated Rejection Without Detectable Donor-specific Antibody Releases Donor-derived Cell-free DNA: Results From the Trifecta Study.
    Halloran PF; Reeve J; Madill-Thomsen KS; Demko Z; Prewett A; Gauthier P; Billings P; Lawrence C; Lowe D; Hidalgo LG;
    Transplantation; 2023 Mar; 107(3):709-719. PubMed ID: 36190186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute Antibody-mediated rejection in liver transplantation: Impact and applicability of the Banff working group on liver allograft pathology 2016 criteria.
    Maurice JB; Nwaogu A; Gouda M; Shaw O; Sanchez-Fueyo A; Zen Y
    Hum Pathol; 2022 Sep; 127():67-77. PubMed ID: 35728694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of Serum Angiotensin II Type 1 Receptor Antibodies at the Time of Renal Allograft Rejection.
    Lee H; Kim JI; Moon IS; Chung BH; Yang CW; Kim Y; Han K; Oh EJ
    Ann Lab Med; 2015 May; 35(3):314-20. PubMed ID: 25932439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C4D deposition and positive posttransplant crossmatch are not necessarily markers of antibody-mediated rejection in renal allograft recipients.
    Banasik M; Boratyńska M; Nowakowska B; Haloń A; Kościelska-Kasprzak K; Drulis-Fajdasz D; Patrzałek D; Weyde W; Klinger M
    Transplant Proc; 2007 Nov; 39(9):2718-20. PubMed ID: 18021967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute Antibody-Mediated Rejection in Kidney Transplant Based on the 2013 Banff Criteria: Single-Center Experience in Uruguay.
    Nin M; Coitiño R; Kurdian M; Orihuela L; Astesiano R; Garau M; López D; Rievas G; Rodriguez I; González-Martínez F; Noboa O
    Transplant Proc; 2016 Mar; 48(2):612-5. PubMed ID: 27110014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular diagnosis of ABMR with or without donor-specific antibody in kidney transplant biopsies: Differences in timing and intensity but similar mechanisms and outcomes.
    Halloran PF; Madill-Thomsen KS; Pon S; Sikosana MLN; Böhmig GA; Bromberg J; Einecke G; Eskandary F; Gupta G; Hidalgo LG; Myslak M; Viklicky O; Perkowska-Ptasinska A;
    Am J Transplant; 2022 Aug; 22(8):1976-1991. PubMed ID: 35575435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular phenotype of kidney transplant indication biopsies with inflammation in scarred areas.
    Halloran PF; Matas A; Kasiske BL; Madill-Thomsen KS; Mackova M; Famulski KS
    Am J Transplant; 2019 May; 19(5):1356-1370. PubMed ID: 30417539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Trifecta Study: Comparing Plasma Levels of Donor-derived Cell-Free DNA with the Molecular Phenotype of Kidney Transplant Biopsies.
    Halloran PF; Reeve J; Madill-Thomsen KS; Demko Z; Prewett A; Billings P;
    J Am Soc Nephrol; 2022 Feb; 33(2):387-400. PubMed ID: 35058354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor-Specific Antibody Is Associated with Increased Expression of Rejection Transcripts in Renal Transplant Biopsies Classified as No Rejection.
    Madill-Thomsen KS; Böhmig GA; Bromberg J; Einecke G; Eskandary F; Gupta G; Hidalgo LG; Myslak M; Viklicky O; Perkowska-Ptasinska A; Halloran PF;
    J Am Soc Nephrol; 2021 Nov; 32(11):2743-2758. PubMed ID: 34253587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and pathological analyses of transplant glomerulopathy cases.
    Shimizu T; Ishida H; Toki D; Nozaki T; Omoto K; Tanabe K; Honda K; Koike J
    Nephrology (Carlton); 2014 Jun; 19 Suppl 3():21-6. PubMed ID: 24842817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.